Therapeutic insights into increasing the Chemosensitivity of Human Cancer cells: Metformin, the widely used drug to treat NIDDM, sensitizes chemoreistant cancer cells via down regulation of PEBP4 , 22/July/2014, 6.27 am

MiRNA-based therapy for cancer: Tumor suppressor MiRNA-135 suppresses the expression of oncogenic miR-222 in a cell context dependent manner via down regulation of its target gene, 22/July/2014, 5.45 am
July 22, 2014
Treating human Metastatic cancers with an NIDDM drug: Acarbose, an α-glucosidase inhibitor, suppresses the expression of MMP-1 via up regulation of its target gene, 22/July/2014, 7.16 am
July 22, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Therapeutic insights into increasing the Chemosensitivity of Human Cancer cells: Metformin, the widely used drug to treat NIDDM, sensitizes chemoreistant cancer cells via down regulation of PEBP4 , 22/July/2014, 6.27 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.